4-[(1E)-3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl]benzoic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 4-[(1E)-3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl]benzoic acid
• 英文别名: (E)-4-(3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)benzoic acid；4-[(E)-3-(2,4-dimethoxyphenyl)-3-oxoprop-1-enyl]benzoic acid
• 化学式: C₁₈H₁₆O₅
• 分子量: 312.322
• InChiKey: ZGOJJBQEAOMRNO-BJMVGYQFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-[(1E)-3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl]benzoic acid 、 dihydroartemisinin 在 N,N'-羰基二咪唑 作用下， 以 二氯甲烷 为溶剂， 反应 27.0h， 以75%的产率得到
  参考文献：
  名称：

  Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters

  摘要：

  A series of dihydroartemisinyl-chalcone esters were synthesized through esterification of chalcones with dihydroartemisinin (DHA). The hybrids were screened against chloroquine (CQ) sensitive (3D7) and CQ resistant (W2) strains of intraerythrocytic Plasmodium falciparum parasites, and were all found to be active, with IC50 values ranging between 1.5 and 11 nM against both strains, with SI values over 5800. The esters featuring oxygenated aryl rings (7,10 and 11), were found to be equipotent to DHA, but were 2-3 times more active than artesunate against the 3D7 and W2 strains of the malaria parasites. They were also screened in vitro against a panel of three cancer cell lines consisting of TK-10, UACC-62 and MCF-7. Compound 7, bearing a furan ring, displayed the most potent overall antitumor activity against all three cancer cell lines. TGA revealed that the targeted hybrids were all thermally more stable than DHA, which may be beneficial to the high temperature storage conditions that prevail in malaria endemic countries. During this study, ester 7 was identified as the best candidate for further investigation as a potential drug in search for new, safe and effective antimalarial drugs. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.11.016
• 作为产物：
  描述：

  对醛基苯甲酸 、 2,4-二甲氧基苯乙酮 在 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 以52 %的产率得到4-[(1E)-3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl]benzoic acid
  参考文献：
  名称：

  作为黄嘌呤氧化酶抑制剂的羧化查尔酮和相关黄酮类化合物

  摘要：

  合成了羧基查尔酮和其他相关黄酮类化合物，并作为黄嘌呤氧化酶抑制剂进行了评估，黄嘌呤氧化酶是用于治疗高尿酸血症、痛风和其他疾病的合成药物和草药的已知靶点。A 环上带有羟基、甲氧基和乙氧基的 4-羧化查耳酮被发现具有体外抑制活性，IC 50值在 0.057 至 0.26 μM 范围内，比别嘌呤醇强 10-60 倍。具有 Δ 3,9-同型异黄酮和黄酮支架的结构相关的羧酸也显示出针对黄嘌呤氧化酶的微摩尔活性。同时，二氢查尔酮和Δ2,3-高异黄酮羧酸及其氧杂-类似物的抑制剂效果低两个数量级以上。动力学和分子对接研究表明，羧基查尔酮和Δ3,9-同异黄酮类化合物是混合型抑制剂，它们大多与占据黄嘌呤氧化酶活性位点的游离酶结合。 图形概要

  DOI：

  10.1007/s00044-023-03109-8

文献信息

• A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia
  作者：Ana C.A. de Souza、Mattia Mori、Larissa Sens、Ruth F. Rocha、Tiago Tizziani、Luiz F.S. de Souza、Louise Domeneghini Chiaradia-Delatorre、Maurizio Botta、Ricardo J. Nunes、Hernán Terenzi、Angela C.O. Menegatti

  DOI：10.1016/j.bmcl.2020.127350

  日期：2020.8

  Identification of allosteric inhibitors of PTPs has attracted great interest as a new strategy to overcome the challenge of discover potent and selective molecules for therapeutic intervention. YopH is a virulence factor of the genus Yersinia , validated as an antimicrobial target. The finding of a second substrate binding site in YopH has revealed a putative allosteric site that could be further exploited. Novel chalcone compounds that inhibit PTPs activity were designed and synthesized. Compound 3j was the most potent inhibitor, interestingly, with different mechanisms of inhibition for the panel of enzymes evaluated. Further, our results showed that com- pound 3j is an irreversible non-competitive inhibitor of YopH that binds to a site different than the catalytic site, but close to the well-known second binding site of YopH.
• Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters
  作者：Frans J. Smit、Riëtte A. van Biljon、Lyn-Marie Birkholtz、David D. N'Da

  DOI：10.1016/j.ejmech.2014.11.016

  日期：2015.1

  A series of dihydroartemisinyl-chalcone esters were synthesized through esterification of chalcones with dihydroartemisinin (DHA). The hybrids were screened against chloroquine (CQ) sensitive (3D7) and CQ resistant (W2) strains of intraerythrocytic Plasmodium falciparum parasites, and were all found to be active, with IC50 values ranging between 1.5 and 11 nM against both strains, with SI values over 5800. The esters featuring oxygenated aryl rings (7,10 and 11), were found to be equipotent to DHA, but were 2-3 times more active than artesunate against the 3D7 and W2 strains of the malaria parasites. They were also screened in vitro against a panel of three cancer cell lines consisting of TK-10, UACC-62 and MCF-7. Compound 7, bearing a furan ring, displayed the most potent overall antitumor activity against all three cancer cell lines. TGA revealed that the targeted hybrids were all thermally more stable than DHA, which may be beneficial to the high temperature storage conditions that prevail in malaria endemic countries. During this study, ester 7 was identified as the best candidate for further investigation as a potential drug in search for new, safe and effective antimalarial drugs. (C) 2014 Elsevier Masson SAS. All rights reserved.
• Carboxylated chalcones and related flavonoids as inhibitors of xanthine oxidase
  作者：Oleksandr L. Kobzar、Alona V. Tatarchuk、Galyna P. Mrug、Svitlana P. Bondarenko、Bohdan A. Demydchuk、Mykhaylo S. Frasinyuk、Andriy I. Vovk

  DOI：10.1007/s00044-023-03109-8

  日期：2023.8

  9-homoisoflavonoid and flavone scaffolds also showed micromolar activity towards xanthine oxidase. At the same time, dihydrochalcone and Δ2,3-homoisoflavonoid carboxylic acids as well as their oxa-analogues were more than two orders of magnitude less effective inhibitors. Kinetic and molecular docking studies indicated that the carboxylated chalcones and Δ3,9-homoisoflavonoids are mixed-type inhibitors

  合成了羧基查尔酮和其他相关黄酮类化合物，并作为黄嘌呤氧化酶抑制剂进行了评估，黄嘌呤氧化酶是用于治疗高尿酸血症、痛风和其他疾病的合成药物和草药的已知靶点。A 环上带有羟基、甲氧基和乙氧基的 4-羧化查耳酮被发现具有体外抑制活性，IC 50值在 0.057 至 0.26 μM 范围内，比别嘌呤醇强 10-60 倍。具有 Δ 3,9-同型异黄酮和黄酮支架的结构相关的羧酸也显示出针对黄嘌呤氧化酶的微摩尔活性。同时，二氢查尔酮和Δ2,3-高异黄酮羧酸及其氧杂-类似物的抑制剂效果低两个数量级以上。动力学和分子对接研究表明，羧基查尔酮和Δ3,9-同异黄酮类化合物是混合型抑制剂，它们大多与占据黄嘌呤氧化酶活性位点的游离酶结合。 图形概要